BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Invuity, Inc. Wins 2013 Red Herring Top 100 North America Award


5/31/2013 9:39:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, May 30, 2013 /PRNewswire/ -- Invuity®, a leading developer of advanced visualization devices to optimize minimal access and minimally invasive surgeries, announced today the company has been selected as a winner of the Red Herring's 2013 Top 100 Award for North America, honoring the year's most promising private technology companies in the region. The company was chosen from among nearly a thousand prominent technology start-ups in the United States and Canada in recognition of its outstanding technological innovation.

Companies were evaluated on both quantitative and qualitative criteria, such as financial performance, technology innovation and intellectual property, management quality, business model, customer footprint, and market penetration.

"Invuity is dedicated to providing superior, advanced illumination for minimally invasive surgeries," said Philip Sawyer, CEO of Invuity. "This is a much needed component to enabling these surgeries, and we are really proud of our contribution to patients and the health care system as a whole. Our proprietary technology is being adopted as an integral part of many procedures across an array of surgical specialties. We are gratified as this award recognizes the dedication and commitment of our employees and investors, as well as the physicians who put Eigr to use every day."

More information about the selection process can be found at www.redherring.com/top-100.

About Eigr

Eigr technology incorporates a proprietary optical waveguide technology with a complex geometry of integrated microstructures to shape illumination within the operative space. Eigr broadly projects thermally cool, brilliant light to uniformly illuminate deep surgical cavities, providing unsurpassed visualization while virtually eliminating shadows, glare and thermal hazards. Eigr waveguides are single use products.

About Invuity®

Invuity develops advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries. The company's products incorporate its proprietary Eigr technology into sophisticated hand-held illumination devices and access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery. The company is headquartered in San Francisco, CA. For more information, visit www.invuity.com.

Invuity and Eigr are trademarks or registered trademarks of Invuity, Inc.

SOURCE Invuity



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES